TR200401141T4 - Tioamid oksazolidonların kemik erimesi ve osteoporoz tedavisinde kullanımı - Google Patents

Tioamid oksazolidonların kemik erimesi ve osteoporoz tedavisinde kullanımı

Info

Publication number
TR200401141T4
TR200401141T4 TR2004/01141T TR200401141T TR200401141T4 TR 200401141 T4 TR200401141 T4 TR 200401141T4 TR 2004/01141 T TR2004/01141 T TR 2004/01141T TR 200401141 T TR200401141 T TR 200401141T TR 200401141 T4 TR200401141 T4 TR 200401141T4
Authority
TR
Turkey
Prior art keywords
osteoporosis
treatment
thioamide
oxazolidones
bone resorption
Prior art date
Application number
TR2004/01141T
Other languages
English (en)
Inventor
Mesfin Gebre-Mariam
K. Jensen Richard
Original Assignee
Pharmacia & Upjohn Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Company filed Critical Pharmacia & Upjohn Company
Publication of TR200401141T4 publication Critical patent/TR200401141T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Kemik erimesi ve osteoporoz tedavisi için tioamid oksazolidinonlarin kullanimi saglanmaktadir.
TR2004/01141T 2000-04-20 2001-04-17 Tioamid oksazolidonların kemik erimesi ve osteoporoz tedavisinde kullanımı TR200401141T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19868800P 2000-04-20 2000-04-20

Publications (1)

Publication Number Publication Date
TR200401141T4 true TR200401141T4 (tr) 2004-07-21

Family

ID=22734385

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/01141T TR200401141T4 (tr) 2000-04-20 2001-04-17 Tioamid oksazolidonların kemik erimesi ve osteoporoz tedavisinde kullanımı

Country Status (14)

Country Link
US (1) US20020010341A1 (tr)
EP (1) EP1274426B1 (tr)
JP (1) JP2003531167A (tr)
AT (1) ATE264101T1 (tr)
AU (2) AU2001253113B2 (tr)
CA (1) CA2405543A1 (tr)
DE (1) DE60102812T2 (tr)
DK (1) DK1274426T3 (tr)
ES (1) ES2218407T3 (tr)
NZ (1) NZ522080A (tr)
PT (1) PT1274426E (tr)
TR (1) TR200401141T4 (tr)
WO (1) WO2001080841A2 (tr)
ZA (1) ZA200208269B (tr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
FR2841472B1 (fr) * 2002-06-28 2006-02-24 Agronomique Inst Nat Rech Composition nutritionnelle ou therapeutique contenant le compose hesperidine ou l'un de ses derives
FR2853549B1 (fr) * 2003-04-11 2007-11-09 Agronomique Inst Nat Rech Composition nutritionnelle ou therapeutique contenant le compose oleuropeine ou l'un de ses derives
EP1874782A1 (en) 2005-04-15 2008-01-09 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
WO2007000644A1 (en) 2005-06-29 2007-01-04 Pharmacia & Upjohn Company Llc Homomorpholine oxazolidinones as antibacterial agents
US7618989B2 (en) 2006-08-15 2009-11-17 Wyeth Tricyclic oxazolidone derivatives useful as PR modulators
FR3005419B1 (fr) 2013-05-13 2015-09-04 Agronomique Inst Nat Rech Utilisation d'une association de deux composes pour le traitement et/ou la prevention de troubles osseux
FR3066919B1 (fr) 2017-06-06 2019-08-02 Institut National De La Recherche Agronomique (Inra) Composition de phycocyanine pour son utilisation pour inhiber la resorption osseuse.
WO2021184339A1 (en) 2020-03-20 2021-09-23 Merck Sharp & Dohme Corp. Oxazolidinone compound and methods of use thereof as an antibacterial agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0710657B1 (de) * 1994-11-02 1998-08-26 MERCK PATENT GmbH Adhäsionsrezeptor-Antagonisten
DE19516483A1 (de) * 1995-05-05 1996-11-07 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
CN1138765C (zh) * 1997-05-30 2004-02-18 法玛西雅厄普约翰美国公司 带有硫代羰基功能基的噁唑烷酮抗菌剂

Also Published As

Publication number Publication date
EP1274426A2 (en) 2003-01-15
ES2218407T3 (es) 2004-11-16
JP2003531167A (ja) 2003-10-21
AU5311301A (en) 2001-11-07
WO2001080841A2 (en) 2001-11-01
PT1274426E (pt) 2004-08-31
EP1274426B1 (en) 2004-04-14
WO2001080841A3 (en) 2002-04-04
DE60102812T2 (de) 2005-06-16
DE60102812D1 (de) 2004-05-19
AU2001253113B2 (en) 2005-02-03
NZ522080A (en) 2004-04-30
US20020010341A1 (en) 2002-01-24
ZA200208269B (en) 2004-02-11
CA2405543A1 (en) 2001-11-01
DK1274426T3 (da) 2004-06-21
ATE264101T1 (de) 2004-04-15

Similar Documents

Publication Publication Date Title
ATE498359T1 (de) Chirurgische vorrichtungen
DK1377245T3 (da) Immunstimulerende belægning af kirurgiske indretninger
CY1107531T1 (el) Χρηση αναστολεων πρωτεασομης για την αγωγη των διαταραχων ξηρου οφθαλμου
DE60236413D1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
DK1261606T3 (da) Substituerede oxazolidinoner og deres anvendelse inden for blodkoagulationsområdet
EE05507B1 (et) Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
DE60140516D1 (de) Behandlung von fluorkohlenstoff- ausgangsmaterialien
DE60223694D1 (de) Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums
DE60022917D1 (de) Reboxetin zur Behandlung von Migränekopfschmerzen
ID30062A (id) Alanog-analog benzopiran tersubstitusi untuk pengobatan radang
EP1171428A4 (en) FAB-I INHIBITORS
TR200401141T4 (tr) Tioamid oksazolidonların kemik erimesi ve osteoporoz tedavisinde kullanımı
DE60019162D1 (de) Zolmitriptanhaltige arzneizusammensetzungen
PL356784A1 (pl) Substancja do zastosowania w leczeniu łuszczycy
DE60107034D1 (de) Misch- und Ladeöffnung zur medizinischen Behandlung
FI20000635A0 (fi) COMT-inhibiittoreiden käyttö analgeettina
DE50114605D1 (de) No-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz
DE60233740D1 (de) Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit
EE200000163A (et) Protsess kirurgiliste instrumentide puhastamiseks
ATE347888T1 (de) Verwendung von aivlosin zur behandlung und prevention der lawsonia-infektionen in schweinen.
NO20005548D0 (no) Mykobakterieinhibitorer
MXPA03000313A (es) Uso de fosfato de estramustina en el tratamiento de metastasis osea.
IL151493A0 (en) Use of dermaciclane for the treatment of anxiety and depression
BR0209400A (pt) Composição para cuidado de tecido, processo para o tratamento de tecido, e, uso de uma composição
SI1274426T1 (en) Use of thioamide oxazolidinones for the treatment of bone resorption and osteoporosis